UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Patterned low temperature copper-rich deposits using inkjet printing

Applied physics letters, 2002-12, Vol.81 (27), p.5249-5251

2002

Volltextzugriff (PDF)

High performance organic semiconducting thin films: Ink jet printed polythiophene [ rr-P3HT]

Organic electronics, 2001-09, Vol.2 (2), p.65-73

2001

Volltextzugriff (PDF)

Direct legend printing (DLP) on printed circuit boards using piezoelectric inkjet technology

Circuit world, 2002-06, Vol.28 (2), p.24-31

2002

Volltextzugriff (PDF)

Direct legend printing (DLP) on printed circuit boards using piezoelectric inkjet technology

Circuit world, 2001-01, Vol.28 (2), p.24-31

2001

Volltextzugriff (PDF)

ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma

Cancer cell, 2014-11, Vol.26 (5), p.682-694

2014

Volltextzugriff (PDF)

Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial

Leukemia, 2021-08, Vol.35 (8), p.2332-2345

2021

Volltextzugriff (PDF)

Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma

Surgery, 2014-12, Vol.156 (6), p.1410-1418

2014

Volltextzugriff (PDF)

A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's “pick a winner” trial, with the impact of somatic mutations

British journal of haematology, 2022-08, Vol.198 (3), p.535-544

2022

Volltextzugriff (PDF)

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

The New England journal of medicine, 2010-12, Vol.363 (26), p.2511-2521

2010

Volltextzugriff (PDF)

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia

Molecular oncology, 2018-06, Vol.12 (6), p.814-829

2018

Volltextzugriff (PDF)

Hemodynamic instability during surgery for pheochromocytoma: comparing the transperitoneal and retroperitoneal approach in a multicenter analysis of 341 patients

Surgery, 2018-01, Vol.163 (1), p.176-182

2018

Volltextzugriff (PDF)

A comprehensive model to capture electrical discharge and spark channel evolution during spark-ignition processes

Combustion and flame, 2023-02, Vol.248, p.112589, Article 112589

2023

Volltextzugriff (PDF)

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Haematologica (Roma), 2012-02, Vol.97 (2), p.213-218

2012

Volltextzugriff (PDF)

Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients

Surgical endoscopy, 2016-03, Vol.30 (3), p.1051-1059

2016

Volltextzugriff (PDF)

A comprehensive model to capture electrical discharge and spark channel evolution during spark-ignition processes

Combustion and flame, 2022-12, Vol.248

2022

Volltextzugriff (PDF)

Using healthcare claims data to analyze the prevalence of BCR‐ABL‐positive chronic myeloid leukemia in France: A nationwide population‐based study

Cancer medicine (Malden, MA), 2019-06, Vol.8 (6), p.3296-3304

2019

Volltextzugriff (PDF)

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

Journal of clinical oncology, 2017-05, Vol.35 (14), p.1591-1597

2017

Volltextzugriff (PDF)

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study

Experimental hematology, 2018-11, Vol.67, p.41-48

2018

Volltextzugriff (PDF)

Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory

Annals of hematology, 2022-10, Vol.101 (10), p.2241-2255

2022

Volltextzugriff (PDF)

Risk Factors for Postoperative Pancreatic Fistulization Subsequent to Enucleation

Journal of gastrointestinal surgery, 2012-10, Vol.16 (10), p.1883-1887

2012

Volltextzugriff (PDF)

Laparoscopic Compared to Open Repeat Hepatectomy for Colorectal Liver Metastases: a Multi-institutional Propensity-Matched Analysis of Short- and Long-Term Outcomes

World journal of surgery, 2017-12, Vol.41 (12), p.3189-3198

2017

Volltextzugriff (PDF)

PD20-02 SAFETY OF SYNCHRONOUS PENILE PROSTHESIS AND ARTIFICIAL URINARY SPHINCTER IMPLANTATION

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patterned low temperature copper-rich deposits using inkjet printing

High performance organic semiconducting thin films: Ink jet printed polythiophene [ rr-P3HT]

Direct legend printing (DLP) on printed circuit boards using piezoelectric inkjet technology

Direct legend printing (DLP) on printed circuit boards using piezoelectric inkjet technology

ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma

Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial

Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma

Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study)

A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's “pick a winner” trial, with the impact of somatic mutations

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders

Hemodynamic instability during surgery for pheochromocytoma: comparing the transperitoneal and retroperitoneal approach in a multicenter analysis of 341 patients

A comprehensive model to capture electrical discharge and spark channel evolution during spark-ignition processes

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients

A comprehensive model to capture electrical discharge and spark channel evolution during spark-ignition processes

Using healthcare claims data to analyze the prevalence of BCR‐ABL‐positive chronic myeloid leukemia in France: A nationwide population‐based study

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study

Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory

Risk Factors for Postoperative Pancreatic Fistulization Subsequent to Enucleation

A randomized phase II trial of azacitidine +/- epoetin-β in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents

Laparoscopic Compared to Open Repeat Hepatectomy for Colorectal Liver Metastases: a Multi-institutional Propensity-Matched Analysis of Short- and Long-Term Outcomes

PD20-02 SAFETY OF SYNCHRONOUS PENILE PROSTHESIS AND ARTIFICIAL URINARY SPHINCTER IMPLANTATION

Suchergebnisse filtern